
- Volume 0 0
Obese Patients More Likely to Experience Prostate Cancer Relapse
According to a new study publishedin the journal Urology, a recurrentmalignancy is more likely following aprostatectomy in obese men comparedwith men of normal weight. While linkingobesity and the incidence ofprostate cancer is still considered controversial,2 studies have found the diseaserecurrence more common inobese men. One data review included2131 men who had undergone radicalprostatectomy. Over about a 2-yearperiod, 12% of the men experienced arecurrence of the disease. Men whosebody mass index (BMI) was greaterthan 35 were 69% more likely to have arecurrence of prostate cancer thanmen who had a BMI of 25 or less; menwith a BMI greater than 30 had a 31%increased risk of disease recurrence.Researchers suggest that the effect ofexcess fat on hormone levels may beresponsible, along with the difficultyinvolved in operating on an obesepatient. More research is necessary,they write, as is vigilant follow-up carefor obese patients who have undergonea radical prostatectomy.
Ms. Farley is a freelance medicalwriter based in Wakefield, RI.
Articles in this issue
almost 20 years ago
can you READ these Rxs?almost 20 years ago
Compounding HOTLINEalmost 20 years ago
A Quarter Century of Pharmacy Law—And the Fat Lady Is Singingalmost 20 years ago
It's Time for Education on Rx Drug Abusealmost 20 years ago
Improving Quality of Life for Psoriasis Patientsalmost 20 years ago
A Look at Diabetic Retinopathyalmost 20 years ago
The Graying of HIValmost 20 years ago
AutoCarouselalmost 20 years ago
Lexi-Comp Knowledge Solutionalmost 20 years ago
Refill TeleManagerNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

















































































































































































































